Results 241 to 250 of about 34,947 (279)

STEP-HFpEF: Semaglutide safe and efficacious in HFpEF plus obesity

Medicom Conference Report ESC 2023, 2023
openaire   +1 more source

HFPEF AND GLYCEMIC VARIABILITY: GHIDD TRIAL

European Heart Journal Supplements
Abstract Background Recently the guidelines of European Association of Preventive Cardiology reported that the prevalence of diabetes mellitus in patients with diastolic heart failure (HFpEF) is around 31%.
openaire   +1 more source

Cardiac metabolism in HFpEF: from fuel to signalling

Cardiovascular Research, 2023
Federico Capone, Cristian Sotomayor-Flores, David Bode   +2 more
exaly  

Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility

Journal of Cachexia, Sarcopenia and Muscle, 2022
Volker Adams, Ephraim Bernhard Winzer, Anett Jannasch   +2 more
exaly  

Animal models of heart failure with preserved ejection fraction (HFpEF): from metabolic pathobiology to drug discovery

Acta Pharmacologica Sinica, 2023
Peter J Little,, Bpharm
exaly  

The Cardioprotective Effects of Semaglutide Exceed Those of Dietary Weight Loss in Mice With HFpEF

JACC Basic To Translational Science, 2023
Coenraad Withaar, Carolyn S P Lam, Rudolf A De Boer   +2 more
exaly  

HFpEF Scores

JACC: Heart Failure
Barry Greenberg, Paul Heidenreich, Anita Deswal   +2 more
openaire   +1 more source

From HFpEF to “metabolic (dysfunction)-associated HFpEF”: Time to act

Science Bulletin
Zhou, Xiao-Dong, Lip, Gregory Y. H., Zheng, Ming-Hua   +2 more
openaire   +2 more sources

Neurohormonal activation in HFpEF

Nature Reviews Cardiology, 2019
openaire   +2 more sources

Obese HFpEF

JACC
Carolyn S.P. Lam, Dalane W. Kitzman
openaire   +1 more source